Clinical Trials

Incidence of anterior cruciate ligament (ACL) ruptures disproportionately affect female athletes at a rate 4-6 times greater than male counterparts. In addition, females have a reinjury rate 16 times that of healthy female controls and 4 times that of male ACL reconstruction (ACLR) counterparts. After ACL injury and throughout rehabilitation, a ubiquitous impairment that limits athlete progression to return to sport (RTS) is atrophy of the musculature surrounding the knee, termed arthrogenic muscle inhibition (AMI).The focus of the study is to develop an objective, reproducible, and reliable measure of neuromotor activation (directly correlated with AMI) and neuromuscular elicited muscle stiffness ...

The purpose of this study is to compare the clinical results from knee  reconstruction surgery with an irradiated versus a non-irradiated ligament graft.

The purpose of this study is to validate the patient approved knee assessment (PAKA) by providing the questionnaire to patients to assess patient needs, formulate a questionnaire based on this information, and finally validate the questionnaire in assessing the same outcomes as existing questionnaires for clinical use.

The overall objective of this project is to investigate the effects of timing of surgery (early vs. delayed) and timing of post-op rehabilitation (early vs. delayed) for the treatment of military personnel and civilians that have sustained a Multiple Ligament Knee Injury (MLKI).

To determine the optimal dosing regimen and route of administration of tranexamic acid (TXA) [single dose intravenous (IV), double dose intravenous, intravenous + topical, and oral repeated dosing] to minimize post-operative blood loss and transfusion requirements following revision total knee arthroplasty (RTKA).

The purpose of this study is to analyze the difference between the Blood Flow Restriction (BFR) and SHAM-BFR groups in change in muscle diameter (hypertrophy) from 2 weeks pre-operative to 8-10 days post-operative.

The objectives of this study are to produce an allogeneic cartilage bank whereby cartilage tissue is obtained from consented donors who meet 21 CFR 1271 donor eligibility criteria, and to simluate clinical implantation of living donor osteochondral allografts banked from Aim 1, demonstrated to meet both viability and sterility requirements, in patients undergoing osteochondral transplantation in the Mayo clinical practice. Actual grafting using collected cartilage will not occur. This is a process validation study.